Mackenzie Financial’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Mackenzie Financial’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-24,600	Closed	-$1.04M	–	1620
2023 Q2	$1.04M	Sell	24,600 -1,857,642	-99%	-$75.1M	﹤0.01%	861
2023 Q1	$67M	Sell	1,882,242 -429,842	-19%	-$15.6M	0.1%	181
2022 Q4	$84.8M	Buy	2,312,084 +59,448	+3%	+$2.35M	0.14%	157
2022 Q3	$106M	Sell	2,252,636 -7,219	-0.3%	-$466K	0.18%	134
2022 Q2	$162M	Sell	2,259,855 -32,545	-1%	-$2.38M	0.26%	99
2022 Q1	$186M	Buy	2,292,400 +5,889	+0.3%	+$498K	0.25%	99
2021 Q4	$235M	Sell	2,286,511 -47,741	-2%	-$4.58M	0.32%	78
2021 Q3	$204M	Sell	2,334,252 -761,697	-25%	-$68.9M	0.29%	89
2021 Q2	$277M	Buy	3,095,949 +34,722	+1%	+$2.93M	0.39%	68
2021 Q1	$232M	Sell	3,061,227 -140,591	-4%	-$10.6M	0.35%	74
2020 Q4	$218M	Buy	3,201,818 +247,896	+8%	+$15.5M	0.47%	58
2020 Q3	$157M	Buy	2,953,922 +303,726	+11%	+$18.1M	0.39%	75
2020 Q2	$154M	Buy	2,650,196 +410,616	+18%	+$22.1M	0.41%	65
2020 Q1	$88.3M	Sell	2,239,580 -353,679	-14%	-$20.7M	0.28%	96
2019 Q4	$154M	Sell	2,593,259 -32,171	-1%	-$1.73M	0.38%	71
2019 Q3	$140M	Sell	2,625,430 -151,700	-5%	-$7.78M	0.37%	70
2019 Q2	$142M	Sell	2,777,130 -77,372	-3%	-$3.6M	0.37%	72
2019 Q1	$148M	Sell	2,854,502 -348,302	-11%	-$16.9M	0.36%	71
2018 Q4	$126M	Buy	3,202,804 +370,552	+13%	+$17.2M	0.33%	80
2018 Q3	$146M	Buy	2,832,252 +320,098	+13%	+$15.7M	0.36%	79
2018 Q2	$118M	Buy	2,512,154 +598,783	+31%	+$24.8M	0.3%	89
2018 Q1	$67.9M	Buy	1,913,371 +490,000	+34%	+$19.2M	0.17%	131
2017 Q4	$62.1M	Buy	1,423,371 +260,206	+22%	+$12.2M	0.15%	138
2017 Q3	$60.8M	Sell	1,163,165 -1,623	-0.1%	-$90.5K	0.33%	86
2017 Q2	$68.1M	Sell	1,164,788 -32,061	-3%	-$1.67M	0.38%	75
2017 Q1	$54.9M	Buy	1,196,849 +577,034	+93%	+$28.7M	0.32%	83
2016 Q4	$32.6M	Buy	619,815 +296,412	+92%	+$14.3M	0.2%	139
2016 Q3	$14.4M	Buy	323,403 +275,542	+576%	+$12M	0.09%	186
2016 Q2	$1.82M	Buy	+47,861	New	+$2.1M	0.01%	456

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

CFB

Cullen/Frost Bankers San Antonio, Texas $8.81B AUM 22.47% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Mackenzie Financial's SYNH Position: Q3 2023 in Review

Mackenzie Financial sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 24,600 shares — an estimated $1.04M sold.

Mackenzie Financial first reported a position in SYNH in Q2 2016 and held it in 29 quarters. The position peaked at $277M in Q2 2021. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

Mackenzie Financial reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Mackenzie Financial sold 24,600 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $1.04M.
Mackenzie Financial first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2016 and held it in 29 quarters.
Mackenzie Financial's Syneos Health, Inc. Class A Common Stock position peaked at $277M in Q2 2021.
10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Mackenzie Financial's 13F filing for Q3 2023, filed 25 Oct 2023.